Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 75,050	$ 164,164
Marketable investments	203,126	0
Accounts receivable, net of allowance for credit losses of $1,308 and $899, respectively	32,148	31,449
Inventories, net	45,410	39,503
Other current assets and prepaid expenses	17,579	14,545
Total current assets	373,313	249,661
Property and equipment, net	24,470	3,019
Deferred tax asset	698	778
Goodwill	1,339	1,339
Operating lease right-of-use assets	13,771	14,627
Other long-term assets	9,801	10,169
Restricted cash	700	700
Total assets	424,092	280,293
Current liabilities:
Accounts payable	25,365	7,891
Accrued liabilities	47,539	54,100
Operating lease liabilities	2,714	2,419
Deferred revenue	10,098	9,490
Total current liabilities	85,716	73,900
Deferred revenue, net of current portion	1,429	1,335
Operating lease liabilities, net of current portion	12,368	13,483
Convertible notes, net of unamortized debt issuance costs of $9,269 and $4,007, respectively	299,856	134,243
Other long-term liabilities	849	763
Total liabilities	400,218	223,724
Commitments and Contingencies (Note 12)
Stockholders’ equity:
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 19,560,163 and 17,995,344 shares at June 30, 2022 and December 31, 2021, respectively	20	18
Additional paid-in capital	144,628	114,724
Accumulated other comprehensive loss	(183)	0
Accumulated deficit	(120,591)	(58,173)
Total stockholders’ equity	23,874	56,569
Total liabilities and stockholders’ equity	$ 424,092	$ 280,293